4Waheed S, Shaughnessy J D, Van Rhee F, et al. Inter- national staging system and metaphase cytogenetic abnor- malities in the era of gene expression profiling data in multiple myeloma treated with total therapy 2 and 3 proto- cols[J] Cancer, 2011,117(5) :1001-1009.
5Stabler A, Baur A, Bartl R, et al. Contrast enhancement and quantitative signal in MR imaging of mutiple myelo- ma: Assessment of focal and diffuse growth pattern in marrow correlated with biopsies and survival rates [ J ]. AJR Am J Roentgenol, 1996,167(4):1029.
6Baur Melnyk A, Buhmann S, Becker C, et al. Whole- body MRI versus whole-body MDCT for staging of multi- pie myeloma [ J ]. American Journal of Roentgenology, 2008,190 ( 4 ) : 1097-1104.
7Shortt C P, Gleeson T G, Breen K A, et al. Whole-Body MRI Versus PET in Assessment of Multiple Myeloma Dis- ease Activity [ J ]. American Journal of Roentgenology, 2009,192 ( 4 ) : 980-986.
